Peptide vaccine against chikungunya virus: immuno-informatics combined with molecular docking approach

J Transl Med. 2018 Oct 27;16(1):298. doi: 10.1186/s12967-018-1672-7.

Abstract

Background: Chikungunya virus (CHIKV), causes massive outbreaks of chikungunya infection in several regions of Asia, Africa and Central/South America. Being positive sense RNA virus, CHIKV replication within the host resulting in its genome mutation and led to difficulties in creation of vaccine, drugs and treatment strategies. Vector control strategy has been a gold standard to combat spreading of CHIKV infection, but to eradicate a species from the face of earth is not an easy task. Therefore, alongside vector control, there is a dire need to prevent the infection through vaccine as well as through antiviral strategies.

Methods: This study was designed to find out conserved B cell and T cell epitopes of CHIKV structural proteins through immuno-informatics and computational approaches, which may play an important role in evoking the immune responses against CHIKV.

Results: Several conserved cytotoxic T-lymphocyte epitopes, linear and conformational B cell epitopes were predicted for CHIKV structural polyprotein and their antigenicity was calculated. Among B-cell epitopes "PPFGAGRPGQFGDI" showed a high antigenicity score and it may be highly immunogenic. In case of T cell epitopes, MHC class I peptides 'TAECKDKNL' and MHC class II peptides 'VRYKCNCGG' were found extremely antigenic.

Conclusion: The study led to the discovery of various epitopes, conserved among various strains belonging to different countries. The potential antigenic epitopes can be successfully utilized in designing novel vaccines for combating and eradication of CHIKV disease.

Keywords: B cell and T cell epitopes; Chikungunya virus (CHIKV); Computational approaches; Vaccine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Allergens / immunology
  • Amino Acid Sequence
  • Chikungunya virus / immunology*
  • Conserved Sequence
  • Epitopes, B-Lymphocyte / chemistry
  • Epitopes, B-Lymphocyte / immunology
  • Epitopes, T-Lymphocyte / chemistry
  • Epitopes, T-Lymphocyte / immunology
  • Histocompatibility Antigens Class I / immunology
  • Humans
  • Molecular Docking Simulation*
  • Phylogeny
  • Vaccines, Subunit / chemistry
  • Vaccines, Subunit / immunology*

Substances

  • Allergens
  • Epitopes, B-Lymphocyte
  • Epitopes, T-Lymphocyte
  • Histocompatibility Antigens Class I
  • Vaccines, Subunit